Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on Association Between Homologous Recombination Genes and the Homologous Recombination Deficiency Status in Chinese Population With Epithelial Ovarian Cancer

NCT04651920 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT04651920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04651920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on Association Between Homologous Recombination Genes and the Homologous Recombination Deficiency Status in Chinese Population With Epithelial Ovarian Cancer
Lead sponsor
Lei Li
Phase
Observational
Overall status
Completed
Start date
November 26, 2020
Completion date
March 26, 2022
Enrollment
240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, brca2 mutation, chinese, epithelial ovarian cancer, homologous recombination deficiency, homologous recombination genes, prognosis